Table 2. Comparison of medication parameters at baseline, one-month, and one-year follow-up.
Baseline | One-month | One-year | |
Beta-blocker | 28 (53 %) | 28 (53 %) | 29 (55 %) |
ACE inhibitor or /with Angiotensin receptor blocker | 50 (96 %) | 50 (96 %) | 48 (92 %) |
Non-anti-aldosterone diuretics | 40 (76 %) | 39 (74 %) | 37 (70 %) |
Anti-aldosterone agents | 42 (80 %) | 42 (80 %) | 42 (80%) |
Antiplatelet/anticoagulant | 48 (92%) | 48 (92%) | 46 (88%) |
Statins | 36 (69%) | 36 (69%) | 37 (70%) |
Cardiac glycosides | 10 (20%) | 10 (20%) | 11 (22%) |